3 ASX 200 shares tipped to rise 20% or more

These ASX 200 stocks remain undervalued.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors often target blue-chip ASX 200 shares for lower volatility and consistent earnings. 

It's often assumed that because these companies are well-established, there is limited upside. 

However, here are some blue-chip stocks that have recently received price targets from brokers indicating upside of 20% or more. 

A senior couple discusses a share trade they are making on a laptop computer.

Image source: Getty Images

Qantas Airways Ltd (ASX: QAN)

With oil prices skyrocketing and geopolitical tension impacting global travel, Qantas shares have faced some volatility recently. 

The company noted that it is facing uncertainty due to Middle East tensions and rising jet fuel refining margins. 

However, it has hedged crude oil exposure and remains confident in fuel supply through April and May. 

Strong international demand – especially to Europe – has led the airline to redeploy aircraft and cut domestic capacity, with higher airfares expected to lift unit revenue by about 5% in the second half of FY26.

These headwinds have pushed its stock price down by 12% year to date. 

In good news for prospective buyers, the Qantas share price could now be a significant value. 

Macquarie recently placed a $11 price target on the airline's shares, which would be a 20% rise from the share price at the time of writing. 

As a bonus, experts are tipping a healthy dividend yield for the ASX 200 company throughout the next few years. 

Telix Pharmaceuticals Ltd (ASX: TLX)

Like many ASX 200 healthcare shares, the Telix stock price has fallen heavily in the last 12 months. 

However, the commercial-stage biopharmaceutical company has rebounded significantly over the past month. 

Brokers believe this could be the start of a longer rally. 

Recently, Bell Potter placed a buy rating and $19 price target on Telix shares after the company announced the refinancing of its convertible note facility. 

The share price at the time of writing is hovering around $14.59, which indicates an upside potential of 30%. 

Life360 Inc (ASX: 360)

Despite now climbing 26% over the last 6 days at the time of writing, the Life360 share price remains significantly below its yearly highs. 

The company's core product is a private family and friends social networking app that allows users to communicate and share their locations.

At the time of writing, this ASX 200 stock is exchanging hands for $22.72 per share. 

However, this is significantly below the $36.02 average price targets of 10 analysts via TradingView. 

Should this ASX 200 stock reach that level in the next 12 months, it would be a 58% rise from current levels. 

Motley Fool contributor Aaron Bell has positions in Telix Pharmaceuticals. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360, Macquarie Group, and Telix Pharmaceuticals. The Motley Fool Australia has positions in and has recommended Life360 and Macquarie Group. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Three men stand on a winner's podium with medals around their necks and their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors were treated to a happy start to the trading week this Monday.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Broker Notes

Down 27%, are Boss Energy shares a buy, hold or sell?

A leading analyst delivers his outlook for Boss Energy’s beaten-down shares.

Read more »

a woman holds a cup to her ear and leans in with a wide mouthed expression on her face as though she is listening to interesting and perhaps surprising information.
Broker Notes

Buy, hold, sell: Dexus, Origin Energy, Magellan shares

Let's start the week with some fresh ratings from Dylan Evans of Catapult Wealth.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Buy, hold, sell: TechnologyOne, Boss Energy, Pro Medicus shares

Let's check out some new ratings on ASX shares today.

Read more »

Man with his head on his head with a red declining arrow and A worried man holds his head and look at his computer as the Megaport share price crashes today
Share Fallers

Down 43%! What on earth happened with Liontown shares in July?

Investors pummelled Liontown shares in July. Time to buy?

Read more »

Female miner smiling in front of a mining vehicle as the Pilbara Minerals share price rises
Broker Notes

How high does Macquarie think PLS Group shares will go?

How much higher could this lithium share go?

Read more »

Woman with a concerned look on her face holding a credit card and smartphone.
Broker Notes

Why experts say Qantas and these ASX shares are sells

Let's find out why they are bearish on these names.

Read more »

Two men in business attire play chess.
Mergers & Acquisitions

Steadfast Group shares: Consortium confirms $6.00 per share proposal

A consortium led by Amwins Group, Dragoneer Investment Group, and KKR has its eyes on the company.

Read more »